ArticleCPT: pharmacometrics & systems pharmacology2022

Population pharmacokinetic-pharmacodynamic analyses of amyloid positron emission tomography and plasma biomarkers for lecanemab in subjects with early Alzheimer's disease.

Seiichi Hayato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.